Zhejiang Jingxin Pharmaceutical Co Ltd Tangible Net Worth Ratio

Latest as of June 2026: 92.9%

Zhejiang Jingxin Pharmaceutical Co Ltd tangible net worth ratio. Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Tangible Net Worth Ratio of 92.9% as of June 2026. This metric is calculated by deducting intangible assets (CN¥426.64 Million) from net assets (CN¥6.04 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of Zhejiang Jingxin Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.

Tangible NW Ratio

92.9%
Tangible equity / total equity

Net Assets (Equity)

CN¥6.04 Billion
CNY

Intangible Assets

CN¥426.64 Million
Goodwill, patents, brand value

Total Assets

CN¥7.95 Billion
CNY

Tangible Net Worth Ratio of Zhejiang Jingxin Pharmaceutical Co Ltd (2001–2025)

Tangible net worth ratio of Zhejiang Jingxin Pharmaceutical Co Ltd from 2001 to 2025. This chart shows how Zhejiang Jingxin Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 25 annual periods from 2001 to 2025. As of June 2026, the ratio stands at 92.9%, reflecting net assets of CN¥6.04 Billion with intangible assets of CN¥426.64 Million CNY. See working capital to net assets of Zhejiang Jingxin Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.

Zhejiang Jingxin Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2001–2025)

Zhejiang Jingxin Pharmaceutical Co Ltd tangible net worth ratio by year from 2001 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd from 2001 to 2025, covering 25 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Zhejiang Jingxin Pharmaceutical Co Ltd (002020) market capitalisation.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 92.6% CN¥5.87 Billion CN¥431.89 Million CN¥8.12 Billion ▼ -1.0 pp
2024 93.6% CN¥6.00 Billion CN¥382.26 Million CN¥8.48 Billion ▲ +0.9 pp
2023 92.8% CN¥5.54 Billion CN¥401.26 Million CN¥7.99 Billion ▲ +0.9 pp
2022 91.9% CN¥5.17 Billion CN¥418.59 Million CN¥7.36 Billion ▼ -5.2 pp
2021 97.2% CN¥4.84 Billion CN¥137.73 Million CN¥6.42 Billion ▲ +1.0 pp
2020 96.2% CN¥3.93 Billion CN¥150.77 Million CN¥5.67 Billion ▲ +0.7 pp
2019 95.5% CN¥3.71 Billion CN¥166.57 Million CN¥5.63 Billion ▼ -0.5 pp
2018 96.0% CN¥3.57 Billion CN¥141.23 Million CN¥4.99 Billion ▲ +0.0 pp
2017 96.0% CN¥3.97 Billion CN¥157.92 Million CN¥4.90 Billion ▲ +3.2 pp
2016 92.8% CN¥2.43 Billion CN¥174.39 Million CN¥3.29 Billion ▲ +1.2 pp
2015 91.6% CN¥2.26 Billion CN¥190.58 Million CN¥2.94 Billion ▼ -0.7 pp
2014 92.3% CN¥1.40 Billion CN¥108.37 Million CN¥2.06 Billion ▲ +6.2 pp
2013 86.0% CN¥817.98 Million CN¥114.22 Million CN¥1.32 Billion ▲ +1.6 pp
2012 84.5% CN¥772.58 Million CN¥120.06 Million CN¥1.30 Billion ▼ -4.0 pp
2011 88.5% CN¥766.17 Million CN¥88.46 Million CN¥1.19 Billion ▲ +16.7 pp
2010 71.7% CN¥320.13 Million CN¥90.50 Million CN¥949.15 Million ▲ +1.7 pp
2009 70.1% CN¥307.17 Million CN¥91.95 Million CN¥917.22 Million ▲ +3.7 pp
2008 66.4% CN¥303.19 Million CN¥102.02 Million CN¥953.08 Million ▲ +1.1 pp
2007 65.2% CN¥299.61 Million CN¥104.21 Million CN¥1.02 Billion ▼ -9.1 pp
2006 74.3% CN¥294.62 Million CN¥75.67 Million CN¥772.85 Million ▼ -0.8 pp
2005 75.1% CN¥289.64 Million CN¥72.01 Million CN¥568.91 Million ▼ -0.6 pp
2004 75.7% CN¥284.03 Million CN¥68.94 Million CN¥465.14 Million ▲ +0.3 pp
2003 75.4% CN¥88.44 Million CN¥21.75 Million CN¥258.80 Million ▲ +6.1 pp
2002 69.3% CN¥63.02 Million CN¥19.34 Million CN¥182.37 Million ▼ -11.2 pp
2001 80.5% CN¥40.67 Million CN¥7.91 Million CN¥152.50 Million —
pp = percentage points